💼 Three States Challenge Trump Administration’s Cannabis Rescheduling Move

Attorneys general from Nebraska, Indiana, and Louisiana have filed a federal court petition seeking to overturn the Trump administration’s decision to reschedule certain medical cannabis products from Schedule I to Schedule III, arguing the move exceeds federal authority and violates procedural requirements. The policy shift would apply to FDA-approved cannabis drugs and products from state-licensed medical programs, but not recreational marijuana, and is part of a broader federal effort to reclassify cannabis. If successful, the legal challenge could reverse one of the most significant recent changes to federal cannabis policy, highlighting ongoing divisions among states as regulators prepare for further hearings that may determine marijuana’s long-term status nationwide. (Yahoo!News)

🩺 Study Finds Cannabis Significantly Improves Pain in Fibromyalgia and Arthritis Patients

A clinical study found that cannabis-based treatments led to significant improvements in pain and related symptoms among patients with fibromyalgia, rheumatoid arthritis and osteoarthritis, suggesting benefits from both THC-containing and non‑intoxicating cannabinoid formulations. Participants using various cannabinoid capsules over 12 weeks reported reduced pain along with better sleep, mental health and overall quality of life, with results showing consistent effectiveness across different product types. The findings highlight cannabis’s potential as an alternative or complementary option for chronic pain management, particularly for patients who do not respond well to traditional treatments, though researchers note the need for further study on dosing and long‑term effects. (Marijuana Moment)

🪖 Smoakland Launches “1776 Compassion Project” Offering Free Medical Cannabis to Veterans

Smoakland has introduced the “1776 Compassion Project,” a program providing eligible California military veterans with a free year’s supply of medical cannabis, defined as one ounce of product delivered monthly through 2026. The initiative aims to reduce financial barriers for veterans using cannabis to manage conditions like PTSD, chronic pain and service‑related injuries, especially as federal policy evolves to expand access but still leaves many patients paying out of pocket. By stepping in ahead of broader systemic change, the company is positioning the program as both a response to shifting cannabis regulations and a direct effort to improve affordability and access for veteran healthcare.

👉 Read The Full Study Here

✈️ DEA Cannabis Registration Form Sparks Self‑Incrimination Concerns

A new DEA registration form required for cannabis businesses entering the federal Schedule III system is raising legal concerns because it asks applicants to disclose past involvement in federally unauthorized cannabis activity, effectively forcing many operators to admit to actions that were illegal under federal law at the time. Industry experts warn this creates a potential self‑incrimination issue, as most state‑licensed companies previously operated without DEA approval due to cannabis’s former Schedule I status. Although regulators say the question is intended to support fair evaluation rather than block applicants, the requirement highlights ongoing tension between state legalization and federal enforcement risks as the industry transitions into a new regulatory framework. (High Times)

🗓️ Continued Cannabis News & Events

• FundCanna: $60 Million Senior Credit Facility Secured To Expand Cannabis Funding Platform

• ‘Saturating our communities’: Delaware lawmakers debate intoxicating hemp restrictions as federal crackdown looms

• Here’s how a new law will change Minnesota’s cannabis and hemp industries

• Lawmakers push Trump to pardon cannabis prisoners